APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buprenorphine Transdermal Patches

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Buprenorphine Transdermal Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025174 pages

Choose your research edition.

Industry ResearchBuprenorphine Transdermal Patches Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Buprenorphine Transdermal Patches Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Buprenorphine Transdermal Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buprenorphine Transdermal Patches Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Buprenorphine Transdermal Patches Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Buprenorphine Transdermal Patches market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buprenorphine Transdermal Patches include Luye Pharma, PurduePharma and Grunenthal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buprenorphine Transdermal Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buprenorphine Transdermal Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buprenorphine Transdermal Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buprenorphine Transdermal Patches market size, projected growth trends, production technologies, key applications, and end-use industries.

Buprenorphine Transdermal Patches Segment by Company

Luye Pharma

PurduePharma

Grunenthal

Buprenorphine Transdermal Patches Segment by Type

10mcg/h

15 mcg/h

20 mcg/h

5mcg/h

7.5mcg/h

Buprenorphine Transdermal Patches Segment by Application

Relieve Cancer Pain

Other

Buprenorphine Transdermal Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Transdermal Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Transdermal Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Transdermal Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buprenorphine Transdermal Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Buprenorphine Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Buprenorphine Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Buprenorphine Transdermal Patches Industry Trends Table 2. Buprenorphine Transdermal Patches Industry Drivers Table 3. Buprenorphine Transdermal Patches Industry Opportunities and Challenges Table 4. Buprenorphine Transdermal Patches Industry Restraints Table 5. Global Buprenorphine Transdermal Patches Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Buprenorphine Transdermal Patches Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Buprenorphine Transdermal Patches Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturers Table 9. Global Buprenorphine Transdermal Patches Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Buprenorphine Transdermal Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Buprenorphine Transdermal Patches Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Buprenorphine Transdermal Patches Manufacturers, Product Type & Application Table 13. Global Buprenorphine Transdermal Patches Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Buprenorphine Transdermal Patches by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mcg/h Table 17. Major Manufacturers of 15 mcg/h Table 18. Major Manufacturers of 20 mcg/h Table 19. Major Manufacturers of 5mcg/h Table 20. Major Manufacturers of 7.5mcg/h Table 21. Global Buprenorphine Transdermal Patches Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 23. Global Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 24. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2026) Table 25. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2027-2032) Table 26. Global Buprenorphine Transdermal Patches Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (k units) Table 28. Global Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (k units) Table 29. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2026) Table 30. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Relieve Cancer Pain Table 32. Major Manufacturers of Other Table 33. Global Buprenorphine Transdermal Patches Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 35. Global Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 36. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2026) Table 37. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2027-2032) Table 38. Global Buprenorphine Transdermal Patches Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (k units) Table 40. Global Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (k units) Table 41. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2026) Table 42. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2027-2032) Table 43. Global Buprenorphine Transdermal Patches Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (k units) Table 45. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2021-2026) Table 46. Global Buprenorphine Transdermal Patches Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Buprenorphine Transdermal Patches Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 50. North America Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 51. Europe Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 53. Europe Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 60. Global Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Buprenorphine Transdermal Patches Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Buprenorphine Transdermal Patches Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2021-2026) Table 64. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2027-2032) Table 65. Luye Pharma Company Information Table 66. Luye Pharma Business Overview Table 67. Luye Pharma Buprenorphine Transdermal Patches Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Luye Pharma Buprenorphine Transdermal Patches Product Portfolio Table 69. Luye Pharma Recent Development Table 70. PurduePharma Company Information Table 71. PurduePharma Business Overview Table 72. PurduePharma Buprenorphine Transdermal Patches Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. PurduePharma Buprenorphine Transdermal Patches Product Portfolio Table 74. PurduePharma Recent Development Table 75. Grunenthal Company Information Table 76. Grunenthal Business Overview Table 77. Grunenthal Buprenorphine Transdermal Patches Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Grunenthal Buprenorphine Transdermal Patches Product Portfolio Table 79. Grunenthal Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Buprenorphine Transdermal Patches Distributors List Table 83. Buprenorphine Transdermal Patches Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Buprenorphine Transdermal Patches Product Image Figure 2. Global Buprenorphine Transdermal Patches Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buprenorphine Transdermal Patches Market Size (2021-2032) & (US$ Million) Figure 4. Global Buprenorphine Transdermal Patches Sales (2021-2032) & (k units) Figure 5. Global Buprenorphine Transdermal Patches Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Buprenorphine Transdermal Patches Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mcg/h Image Figure 9. 15 mcg/h Image Figure 10. 20 mcg/h Image Figure 11. 5mcg/h Image Figure 12. 7.5mcg/h Image Figure 13. Global Buprenorphine Transdermal Patches Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Buprenorphine Transdermal Patches Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2032) Figure 16. Global Buprenorphine Transdermal Patches Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Buprenorphine Transdermal Patches Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2032) Figure 19. Relieve Cancer Pain Image Figure 20. Other Image Figure 21. Global Buprenorphine Transdermal Patches Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Buprenorphine Transdermal Patches Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2032) Figure 24. Global Buprenorphine Transdermal Patches Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Buprenorphine Transdermal Patches Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2032) Figure 27. North America Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2032) Figure 29. U.S. Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2032) Figure 34. Germany Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2032) Figure 41. China Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2032) Figure 49. Brazil Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Buprenorphine Transdermal Patches Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Buprenorphine Transdermal Patches Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Buprenorphine Transdermal Patches Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Figure 60. North America Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Figure 62. Europe Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Buprenorphine Transdermal Patches Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Buprenorphine Transdermal Patches Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10mcg/h
  • 15 mcg/h
  • 20 mcg/h
  • 5mcg/h
  • 7.5mcg/h
Applications
  • Relieve Cancer Pain
  • Other
Companies covered
  • Luye Pharma
  • PurduePharma
  • Grunenthal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Buprenorphine Transdermal Patches Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Buprenorphine Transdermal Patches Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Buprenorphine Transdermal Patches Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Buprenorphine Transdermal Patches Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Buprenorphine Transdermal Patches Market Dynamics
  1. 2.1 Buprenorphine Transdermal Patches Industry Trends
  2. 2.2 Buprenorphine Transdermal Patches Industry Drivers
  3. 2.3 Buprenorphine Transdermal Patches Industry Opportunities and Challenges
  4. 2.4 Buprenorphine Transdermal Patches Industry Restraints
3 Buprenorphine Transdermal Patches Market by Manufacturers
  1. 3.1 Global Buprenorphine Transdermal Patches Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Buprenorphine Transdermal Patches Sales by Manufacturers (2021-2026)
  3. 3.3 Global Buprenorphine Transdermal Patches Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Buprenorphine Transdermal Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buprenorphine Transdermal Patches Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Buprenorphine Transdermal Patches Manufacturers, Product Type & Application
  7. 3.7 Global Buprenorphine Transdermal Patches Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buprenorphine Transdermal Patches Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buprenorphine Transdermal Patches Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buprenorphine Transdermal Patches Tier 1, Tier 2, and Tier 3
4 Buprenorphine Transdermal Patches Market by Type
  1. 4.1 Buprenorphine Transdermal Patches Type Introduction
  2. 4.1.1 10mcg/h
  3. 4.1.2 15 mcg/h
  4. 4.1.3 20 mcg/h
  5. 4.1.4 5mcg/h
  6. 4.1.5 7.5mcg/h
  7. 4.2 Global Buprenorphine Transdermal Patches Sales by Type
  8. 4.2.1 Global Buprenorphine Transdermal Patches Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  10. 4.2.3 Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2032)
  11. 4.3 Global Buprenorphine Transdermal Patches Revenue by Type
  12. 4.3.1 Global Buprenorphine Transdermal Patches Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  14. 4.3.3 Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2032)
5 Buprenorphine Transdermal Patches Market by Application
  1. 5.1 Buprenorphine Transdermal Patches Application Introduction
  2. 5.1.1 Relieve Cancer Pain
  3. 5.1.2 Other
  4. 5.2 Global Buprenorphine Transdermal Patches Sales by Application
  5. 5.2.1 Global Buprenorphine Transdermal Patches Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  7. 5.2.3 Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2032)
  8. 5.3 Global Buprenorphine Transdermal Patches Revenue by Application
  9. 5.3.1 Global Buprenorphine Transdermal Patches Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  11. 5.3.3 Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2032)
6 Global Buprenorphine Transdermal Patches Sales by Region
  1. 6.1 Global Buprenorphine Transdermal Patches Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buprenorphine Transdermal Patches Sales by Region (2021-2032)
  3. 6.2.1 Global Buprenorphine Transdermal Patches Sales by Region (2021-2026)
  4. 6.2.2 Global Buprenorphine Transdermal Patches Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Buprenorphine Transdermal Patches Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Buprenorphine Transdermal Patches Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Buprenorphine Transdermal Patches Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Buprenorphine Transdermal Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Buprenorphine Transdermal Patches Revenue by Region
  1. 7.1 Global Buprenorphine Transdermal Patches Revenue by Region
  2. 7.1.1 Global Buprenorphine Transdermal Patches Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Buprenorphine Transdermal Patches Revenue by Region (2021-2026)
  4. 7.1.3 Global Buprenorphine Transdermal Patches Revenue by Region (2027-2032)
  5. 7.1.4 Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Buprenorphine Transdermal Patches Revenue (2021-2032)
  8. 7.2.2 North America Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Buprenorphine Transdermal Patches Revenue (2021-2032)
  11. 7.3.2 Europe Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Buprenorphine Transdermal Patches Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Buprenorphine Transdermal Patches Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Buprenorphine Transdermal Patches Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Luye Pharma
  2. 8.1.1 Luye Pharma Company Information
  3. 8.1.2 Luye Pharma Business Overview
  4. 8.1.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Luye Pharma Buprenorphine Transdermal Patches Product Portfolio
  6. 8.1.5 Luye Pharma Recent Developments
  7. 8.2 PurduePharma
  8. 8.2.1 PurduePharma Company Information
  9. 8.2.2 PurduePharma Business Overview
  10. 8.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PurduePharma Buprenorphine Transdermal Patches Product Portfolio
  12. 8.2.5 PurduePharma Recent Developments
  13. 8.3 Grunenthal
  14. 8.3.1 Grunenthal Company Information
  15. 8.3.2 Grunenthal Business Overview
  16. 8.3.3 Grunenthal Buprenorphine Transdermal Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grunenthal Buprenorphine Transdermal Patches Product Portfolio
  18. 8.3.5 Grunenthal Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buprenorphine Transdermal Patches Value Chain Analysis
  2. 9.1.1 Buprenorphine Transdermal Patches Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buprenorphine Transdermal Patches Production Mode & Process
  6. 9.2 Buprenorphine Transdermal Patches Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buprenorphine Transdermal Patches Distributors
  9. 9.2.3 Buprenorphine Transdermal Patches Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst